Methotrexate

Methotrexate is an anti-neoplastic antimetabolite used to treat leukemia, lymphoma, and breast cancer by inhibiting DNA synthesis.

Structure of Methotrexate

  • It is a folate analog with the following structural features:
  • Pteridine Ring: Core structure similar to folic acid.
  • Glutamate Residues: Multiple glutamate moieties attached to the pteridine ring.
  • Chemical Formula: C₂⁰H₂⁷N₇O₇
Advertisements

structure of Methotrexate

Mode of Action

  • Methotrexate acts as an antimetabolite and antifolate by:
  • Inhibition of Dihydrofolate Reductase (DHFR): Prevents the conversion of dihydrofolate to tetrahydrofolate, essential for DNA synthesis.
  • Inhibition of Thymidylate Synthase: Reduces dTMP synthesis, hindering DNA replication.
  • Induction of Apoptosis: Causes cytotoxicity in rapidly dividing cells.
Advertisements

Uses of Methotrexate

  • Acute Lymphoblastic Leukemia (ALL): As part of multi-agent chemotherapy.
  • Breast Cancer: In certain treatment protocols.
  • Ovarian Cancer: Alongside other chemotherapeutic agents.
  • Rheumatoid Arthritis: As a disease-modifying antirheumatic drug (DMARD).
  • Psoriasis: In severe cases unresponsive to other treatments.
  • Ectopic Pregnancy: To terminate non-viable pregnancies.

Structure-Activity Relationship (SAR)

SAR Methotrexate

Advertisements

Thank you for reading from Firsthope's notes, don't forget to check YouTube videos!

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.